--- title: "CYTOSORBENTS MEDICAL INC — Capability Statement" uei: "LSF2KFUSY4K7" cage: "5E0N2" canonical: "https://teamingindex.com/contractor/LSF2KFUSY4K7/capability.md" html_url: "https://teamingindex.com/contractor/LSF2KFUSY4K7" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "CYTOSORBENTS MEDICAL INC" primary_naics: "339112" sam_status: "expiring" active_exclusion: false claimed: false tier: "unclaimed" --- # CYTOSORBENTS MEDICAL INC > CYTOSORBENTS MEDICAL INC is a SAM.gov-registered entity based in PRINCETON, NJ 08540-6608. UEI LSF2KFUSY4K7; CAGE 5E0N2; primary NAICS 339112. Compliance posture not provided. SAM registration expires in 30 days. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** CYTOSORBENTS MEDICAL INC - **UEI (SAM.gov Unique Entity ID):** LSF2KFUSY4K7 - **CAGE code:** 5E0N2 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** DE - **Website:** Not on file - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** PRINCETON, NJ 08540-6608 - **Country:** United States - **Congressional district:** NJ-12 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 339112 | Surgical and Medical Instrument Manufacturing | Yes | No | | 541713 | Research and Development in Nanotechnology | No | No | | 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | No | No | - **PSC codes:** None on file Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status No socio-economic designations reported in SAM.gov. Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** SAM registration expires in 30 days - **Registration expires:** 2026-12-12 - **Registration activated:** 2025-12-16 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $0 - **Award history:** 0 awards on record No federal prime awards on record (USAspending.gov). ## Proven teaming graph - No first-tier sub-award reports name this company yet - Source: USAspending.gov sub-award reports (FSRS), sync date not recorded. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 16 SBIR/STTR awards totaling $11M: SBIR Phase I 8, SBIR Phase II 6, STTR Phase I 1, STTR Phase II 1 - By agency: Department of Defense 12, Department of Health and Human Services 4 - SBIR Phase I, Department of Defense (Air Force), 2023, May 12, 2023 to Aug 10, 2023: Novel Sorbent Technology for the Rapid Treatment of Acute Joint Injury and Inflammation ($74,918) - SBIR Phase I, Department of Defense (Air Force), 2023, Nov 1, 2022 to Feb 3, 2023: Novel Oral Sorbent Therapy for the Prevention and Treatment of Traveler’s Diarrhea ($74,955) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2022, Sep 1, 2022 to Apr 30, 2023: Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability ($288,335) - SBIR Phase II, Department of Defense (Defense Health Agency), 2021, Apr 21, 2021 to Aug 20, 2023: Investigation of a potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine ($1,499,987) - SBIR Phase II, Department of Defense (Defense Health Agency), 2020, Sep 24, 2020 to Jan 23, 2023: Development of an Effective Adsorber to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion ($1,098,589) - SBIR Phase II (Direct to Phase II), Department of Health and Human Services (National Institutes of Health), 2018, Aug 20, 2018 to Jul 31, 2021: pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads ($2,970,974) - STTR Phase II, Department of Defense (Defense Health Agency), 2017, May 15, 2017 to Oct 14, 2019: Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion ($999,070) - SBIR Phase II, Department of Defense (Office for Chemical and Biological Defense), 2017, Feb 1, 2017 to Jan 31, 2019: Mycotoxin Adsorption with Hemocompatible Porous Polymer Beads ($999,997) - SBIR Phase I, Department of Defense (Defense Health Agency), 2016, Sep 8, 2016 to Apr 7, 2017: Investigation of a sorbent-based potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine ($149,927) - SBIR Phase I, Department of Defense (Defense Health Agency), 2016, Apr 19, 2016 to Nov 18, 2016: Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion ($149,979) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - Not yet checked against SAM.gov exclusions (search exclusions on SAM.gov: https://sam.gov/search/?index=ex) - Source: SAM.gov Exclusions, sync date not recorded - No confirmed match on the Consolidated Screening List (screened Nov 12, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.